Daniela Simião

Daniela Simião

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2021 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
LRLarissa Naneti Rosa
Larissa Naneti Rosa
ACAdrielle Pieve de Castro
Adrielle Pieve de Castro
WLWilliam Gustavo Lima
William Gustavo Lima
DSDaniela Simião
Daniela Simião
MPMagna Cristina de Paiva
Magna Cristina de Paiva
Introdução: Pneumonia associada à ventilação mecânica (PAVM) é apontada como uma causa significativa de mortalidade em pacientes internados em Unidades de Terapia Intensiva (UTI). Pseudomonas aeruginosa é um importante agente de PAVM que tem apresentado resistência múltipla aos antimicrobianos, sendo considerado um grave problema de saúde pública. Neste contexto, antimicrobianos da classe das polimixinas são considerados a melhor opção terapêutica para o tratamento dessas infecções. Objetivo: Analisar o perfil de susceptibilidade e os mecanismos de resistência às polimixinas em isolados de P. aeruginosa causando PAVM. Métodos: Foi conduzida uma revisão sistemática de acordo a Cochrane Handbook e a pesquisa e análise dos artigos seguiram as normas do Preferred ReportingItems for Systematic Reviews and Meta-Analyses (PRISMA). Resultados: Foram incluídos 22 artigos e a maioria foi publicada a partir de 2015, destacando o ano de 2017 (22,7%), sobretudo em países asiáticos. 1.490 isolados de P. aeruginosa recuperados de pacientes em UTI (sendo 16 UTIs pediátricas) foram analisados. O perfil de susceptibilidade dos isolados a polimixina B e/ou colistina foi determinado pelos métodos de microdiluição (40,9%) e Kirby-Bauer. 2,57% dos isolados de P. aeruginosa foram resistentes a colistina e resistência menor (1,87%) foi observada para polimixina B. Conclusão: Nenhum trabalho investigou a presença do gene plasmidial que codifica resistência as polimixinas (mcr) entre os isolados, apesar deste gene já ter sido relatado nesta espécie. Com isso, tornam-se necessárias mais pesquisas que monitorem a resistência e os mecanismos de resistência de P. aeruginosa as polimixinas, visando preservar a eficácia terapêutica desta classe de antibiótico.

30 January 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
AVAna Paula Gonçalves Coelho Vieira
Ana Paula Gonçalves Coelho Vieira
ASAmanda Neves de Neves de Souza
Amanda Neves de Neves de Souza
WLWilliam Gustavo Lima
William Gustavo Lima
JBJulio Cesar Moreira Brito
Julio Cesar Moreira Brito
DSDaniela Simião
Daniela Simião
Maria Elena De LimaMaria Elena De Lima
Maria Elena De Lima
The urgent global health challenge posed by methicillin-resistant Staphylococcus aureus (MRSA) infections demands effective solutions. Antimicrobial peptides (AMPs) represent promising tools of research of new antibacterial agents and LyeTx I mn∆K, a short synthetic peptide based on the Lycosa erythrognatha spider venom, is a good representative. This study focused on analyzing some antimicrobial activities of LyeTx I mn∆K, including minimum inhibitory and bactericidal concentrations, synergy and resensitization assays, lysis activity, the effect on biofilm, and the bacterial death curve in MRSA. Additionally, its characterization was conducted through isothermal titration calorimetry, dynamic light scattering, calcein release, and finally, efficacy in a mice wound model. The peptide demonstrating remarkable efficacy against planktonic cells and biofilms of MRSA, outperforms vancomycin in terms of rapid bactericidal action and anti-biofilm effects. The mechanism involves significant membrane damage. Interactions with bacterial model membranes, including those with lysylphosphatidylglycerol (LysylPOPG) modifications, highlight versatility and selectivity of this compound. Also, the peptide has the ability to sensitize resistant bacteria to conventional antibiotics, showing potential for combinatory therapy. Furthermore, using an in vivo model, was showed that a formulated gel containing the peptide proved superior to vancomycin in treating MRSA-induced wound in mice. Together the results highlight LyeTx I mnΔK as a promising prototype for the development of effective therapeutic strategies against superficial MRSA infections.

5 September 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
SPSamuel Beiral Alves Pessoa
Samuel Beiral Alves Pessoa
SFSimone Odilia Antunes Fernandes
Simone Odilia Antunes Fernandes
JGJosé Eduardo Gonçalves
José Eduardo Gonçalves
GSGiovana Guerra de Souza
Giovana Guerra de Souza
DSDaniela Simião
Daniela Simião
RCRachel Oliveira Castilho
Rachel Oliveira Castilho
The management of complex wounds, such as burns, pressure ulcers, and chronic skin lesions, remains a major healthcare challenge owing to their prolonged healing process and high susceptibility to complications. These injuries frequently require extended hospitalization, increase the incidence of infections and surgical interventions, and compromise patients' functional capacity and quality of life. Furthermore, currently available wound dressings are often constrained by elevated manufacturing costs, inconsistent therapeutic performance, and reliance on imported biomaterials. To address these challenges, a bioactive wound dressing based on Stryphnodendron adstringens (barbatimão), a medicinal plant recognized by the Brazilian Pharmacopoeia for its wound-healing, anti-inflammatory, antioxidant, and antimicrobial properties, was developed. A standardized plant-derived active pharmaceutical ingredient was obtained through an optimized extraction process and successfully incorporated into a biocompatible polymeric matrix. The engineered membrane was designed to recreate an optimal wound microenvironment by maintaining moisture balance, permitting gas exchange, providing a protective barrier against external contaminants, and enabling sustained release of bioactive phytochemicals to prolong their therapeutic action. The developed biomaterials were thoroughly characterized using Attenuated Total Reflectance Fourier Transform Infrared Spectroscopy (ATR-FTIR), X-ray Diffraction (XRD), Thermogravimetric Analysis (TGA), Differential Thermal Analysis (DTA), Scanning Electron Microscopy (SEM), hydration studies, in vitro release assays, mechanical testing, and cytotoxicity evaluation. Overall, the membranes exhibited excellent physicochemical stability, favorable biocompatibility, and efficient incorporation and sustained release of natural bioactive compounds, demonstrating considerable promise for advanced biomedical and wound healing applications.